Full Press Release Details
YARDLEY, Pa., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present a company overview and business update at the Piper Jaffray 31st Annual Healthcare Conference on Tuesday, December 3, 2019 at 3:00 p.m. ET.
To listen to a webcast of this presentation live, please visit the Investors page of the Optinose website.
A replay of the webcast will be available for 30 days following the conclusion of the event.
Optinose Investor Contact